BTS
ANIK icon

BB&T Securities’s Anika Therapeutics ANIK Stock Holding History

BB&T Securities’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$898K Buy
16,366
+772
+5% +$39.6K 0.01% 846
2019
Q2 		$633K Sell
15,594
-82
-0.5% -$2.99K 0.01% 999
2019
Q1 		$474K Buy
15,676
+7,846
+100% +$269K ﹤0.01% 1102
2018
Q4 		$263K Sell
7,830
-4,047
-34% -$146K ﹤0.01% 1236
2018
Q3 		$500K Sell
11,877
-3,974
-25% -$157K ﹤0.01% 1086
2018
Q2 		$507K Buy
15,851
+476
+3% +$19.6K 0.01% 1070
2018
Q1 		$764K Buy
15,375
+782
+5% +$44.2K 0.01% 870
2017
Q4 		$786K Buy
14,593
+1,327
+10% +$73.4K 0.01% 831
2017
Q3 		$769K Buy
13,266
+3,035
+30% +$159K 0.01% 834
2017
Q2 		$504K Buy
10,231
+895
+10% +$41.2K 0.01% 972
2017
Q1 		$405K Buy
+9,336
New +$446K 0.01% 951

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

BB&T Securities's ANIK Position: Q3 2019 in Review

BB&T Securities increased its Anika Therapeutics (ANIK) stake by 5% in Q3 2019, buying an estimated $39.6K and bringing the position to 16,366 shares worth $898K. The position accounts for 0.01% of the portfolio, ranked #846.

BB&T Securities first reported a position in ANIK in Q1 2017 and has held it in 11 quarters since. 194 funds tracked by Wall St. Rank hold ANIK as of Q3 2019.

  • BB&T Securities held 16,366 shares of Anika Therapeutics worth $898K as of Q3 2019.
  • BB&T Securities bought 772 Anika Therapeutics shares in Q3 2019, an estimated $39.6K.
  • Anika Therapeutics made up 0.01% of BB&T Securities's portfolio in Q3 2019, its #846 holding.
  • BB&T Securities first reported a position in Anika Therapeutics in Q1 2017 and has held it in 11 quarters since.
  • 194 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.